Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Biodistribution of the radioprotective drug /sup 35/S-labeled 3-amino-2-hydroxypropyl phosphorothioate (WR77913)

Journal Article · · Radiat. Res.; (United States)
DOI:https://doi.org/10.2307/3576436· OSTI ID:5722060
3-Amino-2-hydroxypropyl phosphorothioate (WR77913), a less toxic phosphorothioate radioprotector than WR2721, has been labeled with /sup 35/S. The biodistribution of a radioprotective dose of 800 mg/kg was determined in C3H mice bearing RIF-1 tumors as a function of time after intraperitoneal injection and was expressed as percentage injected dose/gram (% ID/g). Levels of /sup 35/S in the blood peaked 10 min after injection, and radioactivity in most tissues was highest at 15 min. Label in most tissues declined markedly between 15 and 60 min, but in gut, salivary glands, tumor, and brain, the levels of radioactivity remained quite stable over 1 hr. Two principal differences between the distribution of label from WR77913 and WR2721 were defined. Although blood levels of /sup 35/S-WR2721 also peaked 10 min after injection, the 10-min blood levels achieved for WR77913 were more than fourfold greater than those attained by WR2721. Maximum levels of WR2721 occurred in most tissues 30 to 60 min after administration of the drug, compared to 15 min for WR77913. The basis for these differences remains to be determined, but these results suggest that the optimum interval between administration of WR77913 and irradiation may be shorter than for WR2721.
Research Organization:
Univ. of Washington Medical School, Seattle
OSTI ID:
5722060
Journal Information:
Radiat. Res.; (United States), Journal Name: Radiat. Res.; (United States) Vol. 102:1; ISSN RAREA
Country of Publication:
United States
Language:
English

Similar Records

Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice
Journal Article · Sun Sep 01 00:00:00 EDT 1991 · Proceedings of the National Academy of Sciences of the United States of America; (United States) · OSTI ID:5823154

Biodistribution and pharmacokinetics of S-35-labeled 5-thio-D-glucose in hamsters bearing pancreatic tumors
Journal Article · Sun Jul 01 00:00:00 EDT 1979 · J. Nucl. Med.; (United States) · OSTI ID:5760059

Fate of radioactive exocrine pancreatic proteins injected into the blood circulation of the rat. Tissue uptake and transepithelial excretion
Journal Article · Mon Oct 31 23:00:00 EST 1983 · Gastroenterology; (United States) · OSTI ID:6671996